A Study of BRY805 in Participants With Advanced Solid Tumors

Clinical trial NCT06289894 · TERMINATED

Trial details

NCT number: NCT06289894
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-03-13
Primary completion: 2025-05-16
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.